Massivemarkets

TMCI

Treace Medical Concepts, Inc. Common Stock

Nasdaq · usd

$4.50+0.22 (+5.14%)
At close · 15-minute delayed
$4.40-0.10 (-2.22%)
As of 7:30:03 PM EST on Nov 4, 2026 · After hours

Treace Medical Concepts, Inc. Common Stock (TMCI) trades at $4.50 (+5.14%) as of 7:30:03 PM EST on Nov 4, 2026, +12.50% over the past month. Market cap is $278.35M, with 8.3 days to cover in short interest.

Stock performance

How Treace Medical Concepts, Inc. Common Stock (TMCI) stock has performed from one day to one year, with its 52-week range.

-1.32%
-$0.06 over 1D
$4.42$4.52$4.63$4.739:30 AM11:05 AM1:00 PM2:40 PM8:00 PM$4.40
1D
+5.14%
1W
-6.83%
1M
+12.50%
YTD
+83.67%
1Y
-27.77%
52-wk range
$1.17 – $6.26

Key statistics

Today's trading snapshot for TMCI: day range, open, previous close, volume and market cap.

Day range
$4.38 – $4.75
Open
$4.38
Prev close
$4.28
Volume
270.64K
Market cap
$278.35M
Shares out
65.03M

Valuation and profitability ratios: P/E, P/S, ROE

Valuation and profitability ratios for Treace Medical Concepts, Inc. Common Stock: P/E, P/S, P/B, ROE and more.

P/E
—
P/S
1.36
P/B
4.11
P/FCF
—
ROE
-87.9%
ROA
-32.9%
Debt/Equity
0.83
Div yield
0.00%

As of Nov 3, 2026

8-K filings

Material corporate events Treace Medical Concepts, Inc. Common Stock has disclosed to the SEC on Form 8-K.

  • Annual meeting resultsMay 20, 2026

    At the 2026 Annual Meeting of Stockholders (the "Meeting") of Treace Medical Concepts, Inc. (the "Company") held on May 19, 2026, the stockholders of the Company voted on the following proposals... The results of voting on the three proposals, including final voting tabulations, are set forth below.

  • The Company is updating its full-year 2026 revenue guidance to $202 million to $212 million. This compares to previous full-year guidance of $200 million to $212 million. The Company's updated full-year 2026 guidance reflects continued case volume growth, offset by previously disclosed headwinds from demand driven product and price mix shift within the Company's expanded bunion portfolio.

  • On January 13, 2026, Treace Medical Concepts, Inc. (the "Company") issued a press release regarding certain preliminary unaudited financial results for the quarter and the year-ended December 31, 2025.

  • Debt retirementDec 18, 2025

    On December 17, 2025, in connection with the Company's entry into the Loan Agreements discussed in Item 1.01 of this Report, the Company used proceeds from the new term loan to pay the outstanding balance and fees under, and subsequently terminated, (1) the Credit and Security Agreement (Term Loan) with MidCap Financial Trust and (2) the Credit and Security Agreement (Revolving Loan) with MidCap Funding IV Trust and lenders thereto (collectively, the "MidCap Loan Agreements"). As provided in the MidCap Loan Agreements, the Company paid prepayment and exit fees totaling $2.3 million for the term and revolving loans.

  • Director departureNov 6, 2025

    On November 3, 2025, Richard W. Mott retired from his position as a member of Board of Directors of Treace Medical Concepts, Inc, including his memberships on the Compensation Committee and the Nominating and Corporate Governance Committee, and as Lead Independent Director of the Board. His decision to retire from the Board was for personal reasons and not the result of any disagreement with the Company.

TMCI short interest

How heavily TMCI is shorted: shares short, days to cover and average daily volume.

Days to cover
8.3
Short interest
1.92M
Avg volume
230.79K

As of · reported to FINRA twice monthly.

TMCI news

The latest news and headlines about Treace Medical Concepts, Inc. Common Stock (TMCI).

Frequently asked questions

What is the Treace Medical Concepts, Inc. Common Stock (TMCI) stock price today?

Treace Medical Concepts, Inc. Common Stock (TMCI) is trading at $4.50 (+5.14% on the day) as of 7:30:03 PM EST on Nov 4, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.

What is Treace Medical Concepts, Inc. Common Stock?

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities.

What is the short interest in TMCI?

As of Oct 15, 2026, TMCI has 1.92M shares short and 8.3 days to cover.

What exchange is TMCI listed on?

Treace Medical Concepts, Inc. Common Stock (TMCI) trades on Nasdaq in USD, in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry.

Build with AI

Build an analysis of TMCI with your agent

Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.

Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a TMCI analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.

Live market data from the Massive API and MCP.Get a free API key

Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.